Get Funding & Stay on Path to a Successful Exit
Our dedicated team of experts understand life science startups and scale-ups. We partner with innovative R&D-driven, founder-led teams to help them gain traction, reach milestones, and scale.
We support our innovators with custom-fit services — regardless of their current growth stage. From core accounting and biz-ops functions to fractional CFO services – as your company reaches milestones and attains success, our solutions evolve to meet your growing and emerging needs.
From pre-seed startup or grant stage, through funding rounds, scale-up & exit – we’re your partner in growth!
Fund & Scale, Faster & Smarter
- Grant Accounting & Compliance (SBIR+)
- Startup Accounting Packages
- Positioning for Capital – Due Dil. Prep & Support
- Investor-Ready Proformas
- Cashflow & Scale-up Planning
- Accounting, Payroll & HR Lite Support
- Fractional CFO Strategy
- R&D Tax Credits (Incl. pre-revenue!)
- Cap Table Integration
- Board & Investor Reporting
- Board & Investor Communications
- Tax Planning & Prep
- Real-time KPI Dashboards
- Audit Prep & Management
- GovCon Accounting (DCAA compliance)
- Exit Prep & Support
Client Testimonials
Life Science & Healthcare
De-Risk Your Life Sciences Venture
& Stretch Your Runway
Affiliations
Innovative Biopharma Venture Taps
Richtr’s Grant Management, Investor Strategy Depth
Background
SiVEC Biotechnologies is biotech company based in Fort Collins, CO at the Research Innovation Center.
SiVEC has developed BactPac™, a live biotherapeutic delivery platform to enable the next generation of nucleic acid and gene editing therapies for both human and animal health. The company’s mission is to use the BactPac™ drug delivery platform to develop first-in-class therapeutics and out-license the platform to pharma companies who need a safe, tissue-targeted method of delivery to advance nucleic acid and gene therapies into clinical stages.
SiVEC has been recently recognized as the 2022 Top Emerging Company by the Biotechnology International Organization (BIO) and has been awarded nearly $4 million in grant funds from federal and state agencies.
The collaborative spirit and diversity in scientific expertise of their team was ripe for supplementation by financial rigor and creativity — to secure current sources of funding and additionally define and execute a clear strategy to attract investors and global licensing partners.
Challenges
 |
Specialized grant accounting needs |
|
Company outgrowing simple accounting functions |
|
Needed fundraising guidance for next growth stage |
Solution
|
Quickly fill in accounting ops functions |
|
Organize and de-risk grant accounting |
|
Focus and organize fundraising strategy |
Results
|
Reduced exposure |
|
Tax savings |
|
Pro-forma ready for investor scrutiny |
Challenges
SiVEC had parlayed its grants, research and intellectual property into a promising biopharma position. Its innovations could make drugs and vaccines across the world more effective.
But they wanted focused expertise in grant accounting, support in financial ops, and guidance in telling their best story to investors so they could take the venture to the next level. Forecasting ability was limited and the path ahead needed illumination.
Solution
Richtr Financial Studio called upon both internal experts and its SME network to ensure SiVEC’s grant accounting was compliant with all legal requirements — also taking over day-to-day accounting functions when another vendor stepped down.
Then intense collaboration began on forecasting, investment, and licensing strategy — Richtr’s knowledge of biotech and relationships with investors accelerated SiVEC’s ability to understand its fundraising targets, build a plan, and get into capital-raising mode.
Results
Richtr administers SiVEC’s grant accounting to this day, yielding tax savings while ensuring compliance. Richtr’s knowledge and connections helped remove obstacles to new international partnerships.
Both teams are collaborating on a new pro forma as Richtr helps SiVEC get in front of the right investors — with the right questions answered in the numbers.